- Clinical Trials
AUSTIN, Texas, March 27, 2017 — Genprex, Inc., a privately held, clinical-stage biopharmaceutical company developing immunogene therapeutics, today announced that Julien Pham, MD, the Company’s Chief Operating Officer, is scheduled to present a corporate overview at two upcoming healthcare investor conferences.
Sachs 5th Annual Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 at 3:00 PM EDT in New York, NY
BioCentury 24th Annual Future Leaders in Biotech Industry – Friday, April 7, 2017 at 11:20 AM EDT in New York, NY
Genprex is a privately held, clinical-stage biopharmaceutical company developing immunogene therapy treatments to increase the treatment options for various cancers….